RE:Cardiol Omicron Don't necessarily disagree with you Bullknit101 however the FDA trials for Covid started in May and were to be completed by the end of this year with results announced in Q1 2022.
I guess what's concerning to me, is that Cardiol was to announce when they were halfway through the LANCER trials and that has not happened yet.
With all the Covid cases in the US over the past 6 months, its mind boggling to me that we haven't received any update from Cardiol on the trials specifically hitting the 50% threshold.
Unfortunately I don't see the urgency or the fast tracking that you are suggesting!
Bullknit101 wrote: As Omicron spreads like wildfire and hospitalizations increase, it is highly likely Cardiol Rx will be fast tracked. Retail investors have short memories but this is going to be huge: "High-risk patients with Cardiovascular Disease (CVD), hospitalized with COVID-19 CardiolRx Cardiol has received approval from the U.S. Food and Drug Administration for its Investigational New Drug application to conduct a Phase II/III clinical trial investigating the efficacy and safety of CardiolRx in the treatment of hospitalized COVID-19 patients with a prior history of, or risk factors for, cardiovascular disease".